Synergistic Hepatoprotection: Molecular Mechanisms And Therapeutic Potential Of Picrorhiza Kurroa And Piper Longum In Liver Disease Management

Abstract

Background: A wide variety of liver diseases, including Drug-induced liver injury (DILI) and Nonalcoholic Fatty Liver Disease (NAFLD), are prevalent all over the World. Historically used as combinations for their multi-targeted effects has yielded unknown appositional effects between Picrorhiza Kurroa and Piper Longum in providing hepatoprotection. This Review aims to examine these possible synergistic effects.

Mechanisms: P. kurroa has the capacity to protect cells from damage by acting on the Nrf2/ARE antioxidant pathway; inhibiting the inflammatory response mediated by NF-kB, as well as down-regulating TGF-beta-mediated fibrogenesis. The main drawback of this is its rapid metabolism which limits clinical efficacy. P. longum is a bioenhancer due to its alkaloid, piperine (or piperine derivative), which also inhibits the CYP450 isoenzymes and P-glycoprotein efflux pumps, thereby increasing the systemic bioavailability of picrosides while adding an antioxidant and anti-inflammatory activity.

Conclusion: All preclinical studies demonstrate that the use of these herbs as a botanical formulation and herbal supplement produce superior biochemical and histological results compared to using individual herbs alone. Due to the abundance of compelling evidence from experimental research, clinical usage is limited by the lack of standardized formulations and large random controlled trials. Future studies should emphasize the validation of the mechanisms through omics-based technology and investigate delivery of these herbs using nanotechnology, as well as provide a rigorous evaluation of the synergy of the botanical formulation in clinical practice for the prevention and treatment of chronic liver disease.